Vaccines are now available to combat rotavirus, the most common cause of severe diarrhea
among children worldwide. We review clinical trial data for available rotavirus vaccines and …

Abstract Background RotaTeq™(RV5; Merck & Co. Inc., USA) and Rotarix™(RV1,
GlaxoSmithKline, Belgium) vaccines, developed to prevent rotavirus diarrhea in children …

Background Despite significant reduction of rotavirus (RV) infections following
implementation of RotaTeq vaccination in Nicaragua, a large burden of patients with …

Background: Nicaragua was the first developing nation to implement routine immunization
with the pentavalent rotavirus vaccine (RV5). In this RV5-immunized population …

We consider inference about the causal effect of a treatment or exposure in the presence of
interference, ie, when one individual's treatment affects the outcome of another individual. In …

Background Childhood diarrhea is one of the major public health problems in Ethiopia.
Multiple factors at different levels contribute to the occurrence of childhood diarrhea. The …

Background Rotavirus infection is the most common cause of acute gastroenteritis globally
in children under 5 years of age and is responsible for approximately 5% of all child deaths …

Abstract Background The Democratic Republic of the Congo (DRC) is one of the countries
with the highest rotavirus mortality rate in the world. The aim of this study was to describe the …

Despite high rotavirus (RV) vaccine coverage (∼ 83%) and good effectiveness (∼ 77%)
against RV-diarrhea hospitalization, RV is still contributing to the burden of diarrhea that …

Статья содержит обзор результатов научных исследований, опубликованных за
последние несколько лет, подтверждающих значительное социально-экономическое …